Suppr超能文献

趋化因子受体(CCR1、CCR2和CXCR4)在人骨髓瘤细胞中的表达的临床意义:与疾病活性和生存的关联。

Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival.

作者信息

Vande Broek Isabelle, Leleu Xavier, Schots Rik, Facon Thiery, Vanderkerken Karin, Van Camp Ben, Van Riet Ivan

机构信息

Department Hematology-Immunology, Vrije Universiteit Brussel, aarbeeklaan 101, 1090 Brussels, Belgium.

出版信息

Haematologica. 2006 Feb;91(2):200-6.

Abstract

BACKGROUND AND OBJECTIVES

The capacity of multiple myeloma (MM) cells to home to and reside in the bone marrow implies that they must be equipped with appropriate adhesion molecules and chemokine receptors to allow transendothelial migration. We and others have previously shown that human MM cells express at least three different chemokine receptors that are functionally involved in MM cell migration, i.e. CCR1, CCR2 and CXCR4. In this study, we analyzed the surface expression of these chemokine receptors on primary MM cells from bone marrow samples.

DESIGN AND METHODS

Chemokine receptor expression was analyzed on bone marrow samples from a large population of patients (n=80) by flow cytometric analysis. The chemokine receptor expression profile was compared with clinical characteristics. Statistical significance was evaluated by Fisher's exact test. Survival curves were constructed using the Kaplan-Meier method. Cox regression analysis was used to determine the effect of chemokine receptor expression on survival.

RESULTS

A heterogeneous expression pattern was observed for the three receptors tested. The chemokine receptor status (CRS) (i.e. no expression versus expression of at least one chemokine receptor), as well as expression of individual chemokine receptors was analyzed in relation to clinical and laboratory features and evaluated for prognostic significance. Chemokine receptor expression was significantly inversely correlated with disease activity: patients with active disease showed a significantly lower expression of CCR1, CCR2, as well as CXCR4 as compared to patients with non-active disease. Furthermore, the chemokine receptor expression profile correlated with serum beta2-microglobulin, C-reactive protein and hemoglobin. CRS, and the individual expressions of CCR1, CCR2 and CXCR4 in diagnostic bone marrow samples (n=70) correlated with survival. Multivariate analysis, using the Cox proportional hazard regression model, identified CRS, along with serum beta-microglobulin, as an independent prognostic factor.

INTERPRETATION AND CONCLUSIONS

This study indicates that the chemokine receptor expression profile of MM cells correlates with disease status and survival of MM patients. This observation might reflect impaired chemoattraction and retention of MM cells within the bone marrow microenvironment, resulting in disease progression.

摘要

背景与目的

多发性骨髓瘤(MM)细胞归巢并驻留在骨髓中的能力表明,它们必须具备合适的黏附分子和趋化因子受体,以实现跨内皮迁移。我们和其他研究人员先前已表明,人类MM细胞表达至少三种在功能上参与MM细胞迁移的不同趋化因子受体,即CCR1、CCR2和CXCR4。在本研究中,我们分析了来自骨髓样本的原发性MM细胞上这些趋化因子受体的表面表达情况。

设计与方法

通过流式细胞术分析了大量患者(n = 80)骨髓样本中的趋化因子受体表达情况。将趋化因子受体表达谱与临床特征进行比较。采用Fisher精确检验评估统计学显著性。使用Kaplan-Meier方法构建生存曲线。采用Cox回归分析确定趋化因子受体表达对生存的影响。

结果

在所检测的三种受体中观察到了异质性表达模式。分析了趋化因子受体状态(CRS)(即无表达与至少一种趋化因子受体表达)以及各个趋化因子受体的表达与临床和实验室特征的关系,并评估其预后意义。趋化因子受体表达与疾病活动显著负相关:与非活动性疾病患者相比,活动性疾病患者的CCR1、CCR2以及CXCR4表达显著降低。此外,趋化因子受体表达谱与血清β2-微球蛋白、C反应蛋白和血红蛋白相关。诊断性骨髓样本(n = 70)中的CRS以及CCR1、CCR2和CXCR4的个体表达与生存相关。使用Cox比例风险回归模型进行的多变量分析确定CRS以及血清β-微球蛋白是独立的预后因素。

解读与结论

本研究表明,MM细胞的趋化因子受体表达谱与MM患者的疾病状态和生存相关。这一观察结果可能反映了MM细胞在骨髓微环境中的化学趋化和滞留受损,从而导致疾病进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验